Aro Biotherapeutics
Philadelphia, PA
Unlocking the Potential of Genetic Medicines Based in Philadelphia, Aro Biotherapeutics is a biotechnology company pioneering the development of tissue-targeted genetic medicines with a platform based on a proprietary protein technology called Centyrins.
arobiotx.comCompany Details
Founded
- 2017
Employees
- Between 20 - 100 employees
Raised
- $166,500,000
Headquarters Location
- Philadelphia, PA
Public
- No
Acquired
- No
CEO
Susan Dillon
Founders
- Karyn ONeilSusan Dillon
Company Collections
These are collections Aro Biotherapeutics is a part of. Click on the collection name to view similar companies.
Aro Biotherapeutics' Industries
Aro Biotherapeutics' Tech Stack
Company Collections For Aro Biotherapeutics
Aro Biotherapeutics Headquarters Location
601 Walnut Street Suite 740, Philadelphia, PA 19106
Total Amount Raised: $166,500,000
Aro Biotherapeutics Funding Rounds
Series B
$41,500,000
Series B Investors
CowenBVF PartnersNorthpond VenturesHealthCapJohnson & Johnson InnovationSeries B
$24,000,000
Series B Investors
CowenSeries A
$88,000,000
Series A Investors
CowenNorthpond VenturesBioMotivRidgeback Capital ManagementIonis PharmaceuticalsBVF PartnersJohnson & Johnson Robotics and Digital SolutionsHealthCapSeries Unknown
$13,000,000
Series Unknown Investors
BioMotivJohnson & Johnson Robotics and Digital Solutions
Funding info provided by Diffbot.
Aro Biotherapeutics Reviews
0 out of 5 stars
Based on 0 reviews
Review data
Share your thoughts
Worked here? Share your experience. Help others decide if this company is right for them. Write a review on Aro Biotherapeutics.